hydroxychloroquine has been researched along with Capsule Opacification in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study whether hydroxychloroquine (HCQ) therapy increases the risks of cataracts in patients with rheumatoid arthritis (RA)." | 8.31 | Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis. ( Ma, X; Shi, X; Wang, YH; Wei, JC; Zhang, Z, 2023) |
| "To study whether hydroxychloroquine (HCQ) therapy increases the risks of cataracts in patients with rheumatoid arthritis (RA)." | 4.31 | Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis. ( Ma, X; Shi, X; Wang, YH; Wei, JC; Zhang, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Ma, X | 1 |
| Wang, YH | 1 |
| Shi, X | 1 |
| Wei, JC | 1 |
1 other study available for hydroxychloroquine and Capsule Opacification
| Article | Year |
|---|---|
Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Capsule Opacification; Humans; Hydroxychloroquine; Retr | 2023 |